Biosante Pharmaceuticals Accounts Payable:
1.129M for Dec. 31, 2012Biosante Pharmaceuticals Historical Accounts Payable Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 1.129M |
| Sept. 30, 2012 | 2.005M |
| June 30, 2012 | 3.836M |
| March 31, 2012 | 3.282M |
| Dec. 31, 2011 | 3.151M |
| Sept. 30, 2011 | 6.042M |
| June 30, 2011 | 6.349M |
| March 31, 2011 | 8.504M |
| Dec. 31, 2010 | 4.864M |
| Sept. 30, 2010 | 4.523M |
| June 30, 2010 | 4.720M |
| March 31, 2010 | 4.003M |
| Dec. 31, 2009 | 2.440M |
| Sept. 30, 2009 | 3.529M |
| June 30, 2009 | 2.550M |
| March 31, 2009 | 2.429M |
| Dec. 31, 2008 | 3.182M |
| Sept. 30, 2008 | 3.420M |
| June 30, 2008 | 2.620M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Accounts Payable
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
For example, accounts payable increases when a company purchases inventory "on account." When the money is repaid, accounts payable decreases.
YCharts takes accounts payable numbers directly from balance sheet line items.
Learn More
BPAX Accounts Payable Benchmarks
| Companies | |
|---|---|
| Repros Therapeutics | 3.24M |
| Teva Pharmaceutical Industries | |
| Eli Lilly and Company | 974.40M |
BPAX Accounts Payable Rankings
| Overall |
59th percentile 3248 of 8002 |
| Sector |
39th percentile 417 of 684 in Healthcare |
| Industry |
47th percentile 130 of 248 in Biotechnology |
BPAX Accounts Payable Range, Past 5 Years
| Minimum | 1.129M | Dec 2012 |
| Maximum | 8.504M | Mar 2011 |
| Average | 3.820M |
